MedTrace Logo

Fetal Growth and Pregnancy Complications Among Women With Heart Disease

NCT03657823 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2018-09-05

No results posted yet for this study

Summary

An increasing proportion of women with heart disease now go through pregnancy and childbirth. More knowledge about the risk of complications and adverse outcomes for the mother and the baby is needed to guide clinical care in this diverse patient group.

The purpose of this study is to, in a cohort of pregnant women with heart disease;

* determine fetal growth, and risk of fetal growth restriction and preterm birth
* determine whether maternal blood biomarkers are associated with development of preeclampsia, the time of delivery and maternal and perinatal adverse outcomes
* determine the risk of hypertensive pregnancy complications

The expected outcome of the project is to increase the knowledge of optimal diagnosis and treatment of women with heart disease that go through pregnancy to be able to improve clinical care and the outcomes for mother and baby.

Conditions

  • Congenital Heart Disease
  • Pregnancy Complications
  • Arrhythmias, Cardiac
  • Hypertension in Pregnancy

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Mette E Estensen, PhD, MD · Oslo University Hospital, Dep. of Cardiology

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2020-04-30
Completion
2020-05-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03657823 on ClinicalTrials.gov